Buy or sell Kaleido BioSciences stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Request Access
View More Companies

Kaleido BioSciences Stock

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.

About Kaleido BioSciences Stock

Tremendous new therapeutic opportunities are emerging from our rapidly expanding knowledge of the human microbiome. Kaleido is exploring this newfound territory through a unique discovery platform that develops novel chemistries targeted at specific microbiome functions. Our approach has produced clinically supported leads in multiple disease areas.

Funding History

August 2015$4.5M
September 2017$60.0M
June 2018$101M

Press

Other Companies

Celularity Logo
Learn More
Learn More
Celularity
Biotechnology Company
5Age (years)
$825MTotal Funding
Eikon Therapeutics Logo
Learn More
Learn More
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that develops live-cell resolution microscopy and engineering for drug discovery.
2Age (years)
$148MTotal Funding
Nerium Biotechnology Logo
Learn More
Learn More
Nerium Biotechnology
Nerium Biotechnology engages in the development of oleander-based products for the treatment of proliferative diseases and viral infections.
15Age (years)
$289KTotal Funding
Qualio Logo
Learn More
Learn More
Qualio
Qualio is a SaaS quality management platform that provides scalable quality management services for life sciences companies.
9Age (years)
$66.2MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Kaleido BioSciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 180K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo